ClinVar Miner

Submissions for variant NM_138694.4(PKHD1):c.7736C>T (p.Ala2579Val)

gnomAD frequency: 0.00019  dbSNP: rs78361537
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000633430 SCV000754654 uncertain significance Autosomal recessive polycystic kidney disease 2024-03-20 criteria provided, single submitter clinical testing This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 2579 of the PKHD1 protein (p.Ala2579Val). This variant is present in population databases (rs78361537, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with PKHD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 528298). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Eurofins Ntd Llc (ga) RCV000731742 SCV000859591 uncertain significance not provided 2018-02-06 criteria provided, single submitter clinical testing
GeneDx RCV000731742 SCV002558269 uncertain significance not provided 2022-01-26 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Fulgent Genetics, Fulgent Genetics RCV005034207 SCV005671748 likely benign Polycystic kidney disease 4 2024-03-05 criteria provided, single submitter clinical testing
Natera, Inc. RCV000633430 SCV002078012 uncertain significance Autosomal recessive polycystic kidney disease 2017-05-06 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV004748870 SCV005360877 uncertain significance PKHD1-related disorder 2024-04-12 no assertion criteria provided clinical testing The PKHD1 c.7736C>T variant is predicted to result in the amino acid substitution p.Ala2579Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.080% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.